Ngā hua rapu - Lebriz Altay

Half-dose photodynamic therapy versus 577 nm subthreshold pulse laser therapy in treatment-naive patients with central serous chorioretinopathy mā Vasilena Sitnilska, Petra Schiller, Tim U. Krohne, Lebriz Altay

Whiwhi kuputuhi katoa

HTRA1/lncRNA HTRA1-AS1 dominates in age-related macular degeneration reticular pseudodrusen genetic risk with no complement involvement mā Samaneh Farashi, Carla J. Abbott, Brendan R. E. Ansell, Zhichao Wu, Lebriz Altay, Ella Arnon, Louis Arnould, Yelena Bagdasarova, Konstantinos Balaskas, Fred K. Chen, Emily Chew, Itay Chowers, Steven Clarke, Catherine Cukras, Cécile Delcourt, Marie-Noëlle Delyfer, Anneke I. den Hollander, Sascha Fauser, Robert P. Finger, Pierre-Henry Gabrielle, Jiru Han, Lauren A. B. Hodgson, Ruth Hogg, Frank G. Holz, Carel Hoyng, Himeesh Kumar, Eleonora M. Lad, Aaron Lee, Ulrich F. O. Luhmann, Matthias M. Mauschitz, Amy J. McKnight, Samuel McLenachan, Aniket Mishra, Ismail Moghul, Luz D. Orozco, Danuta M. Sampson, Liam W. Scott, Vasilena Sitnilska, Scott Song, Amy Stockwell, Anand Swaroop, Jan H. Terheyden, Liran Tiosano, Adnan Tufail, Brian L. Yaspan, MACUSTAR consortium, NICOLA consortium, Alice Pébay, Erica L. Fletcher, Robyn H. Guymer, Melanie Bahlo, On behalf of the Reticular Pseudodrusen Consortium

Whiwhi kuputuhi katoa